NetworkNewsBreaks – Pressure BioSciences, Inc. (
Post# of 1354
(Total Views: 274)
Posted On: 02/27/2020 2:55:25 PM
NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Official Opening of its Ultra Shear Technology(TM) Demonstration Laboratory
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced the official opening of its new Ultra Shear Technology(TM) (“UST”) Demonstration Laboratory. According to the update, the major purpose of the UST Demo Lab, located in the company’s South Easton, Massachusetts facility, is to showcase the ability of the company’s revolutionary UST Platform to process CBD oil into true, high quality, water-soluble nanoemulsions. A second purpose is to invite potential purchasers of Pressure BioSciences’ UST-based BaroShear Systems (initial release expected Q4 2020) to evaluate how their CBD and other product formulations work with the company’s revolutionary UST platform. “The initial reactions from manufacturers of topical and ingestible cannabidiol products processed in our lab during the trial period have been extremely positive. They quickly saw how they could realize substantial cost reductions while eliminating the overloading of poorly water-soluble CBD and other cannabinoids into products to achieve targeted dosing levels,” PBIO President and CEO Richard T. Schumacher said in the news release. “We believe our breakthrough technology platform provides them with a new-found ability to provide safe and effective dosing for their customers, which in turn should stimulate greater growth in the market for CBD-based products overall, and strong sales of our BaroShear product line when it is released to the market later this year.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced the official opening of its new Ultra Shear Technology(TM) (“UST”) Demonstration Laboratory. According to the update, the major purpose of the UST Demo Lab, located in the company’s South Easton, Massachusetts facility, is to showcase the ability of the company’s revolutionary UST Platform to process CBD oil into true, high quality, water-soluble nanoemulsions. A second purpose is to invite potential purchasers of Pressure BioSciences’ UST-based BaroShear Systems (initial release expected Q4 2020) to evaluate how their CBD and other product formulations work with the company’s revolutionary UST platform. “The initial reactions from manufacturers of topical and ingestible cannabidiol products processed in our lab during the trial period have been extremely positive. They quickly saw how they could realize substantial cost reductions while eliminating the overloading of poorly water-soluble CBD and other cannabinoids into products to achieve targeted dosing levels,” PBIO President and CEO Richard T. Schumacher said in the news release. “We believe our breakthrough technology platform provides them with a new-found ability to provide safe and effective dosing for their customers, which in turn should stimulate greater growth in the market for CBD-based products overall, and strong sales of our BaroShear product line when it is released to the market later this year.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼